{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:20:40Z","timestamp":1791724840410,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG082032"],"award-info":[{"award-number":["R21AG082032"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F99AG088436"],"award-info":[{"award-number":["F99AG088436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG066729"],"award-info":[{"award-number":["R01AG066729"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG078374"],"award-info":[{"award-number":["RF1AG078374"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6BX006467"],"award-info":[{"award-number":["IK6BX006467"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Recent research has highlighted widespread dysregulation of alternative polyadenylation in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Here, we identify significant disruptions to 3` UTR polyadenylation in the ALS\/FTLD-TDP mouse model rNLS8 that correlate with changes in gene expression and protein levels through the re-analysis of published RNA sequencing and proteomic data. A subset of these changes are shared with TDP-43 knock-down mice suggesting depletion of endogenous mouse TDP-43 is a contributor to polyadenylation dysfunction in rNLS8 mice. Some conservation exists between alternative polyadenylation in rNLS8 mice and human disease models including in disease relevant genes and biological pathways. Together, these findings support both TDP-43 loss and toxic gain-of-function phenotypes as contributors to the neurodegeneration in rNLS8 mice, nominating its continued utility as a preclinical model for investigating mechanisms of neurodegeneration in ALS\/FTLD-TDP.<\/jats:p>","DOI":"10.1186\/s13041-025-01174-1","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:07:29Z","timestamp":1736860049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alternative 3\u2032 UTR polyadenylation is disrupted in the rNLS8 mouse model of ALS\/FTLD"],"prefix":"10.1186","volume":"18","author":[{"given":"Randall J.","family":"Eck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Valdmanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole F.","family":"Liachko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-7634","authenticated-orcid":false,"given":"Brian C.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"1","key":"1174_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2011","unstructured":"Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2011;13(1):38\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"1174_CR2","doi-asserted-by":"crossref","unstructured":"Arnold FJ, Cui Y, Michels S, Colwin MR, Stockford C, Ye W et al. TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS\/FTD and related disorders. bioRxiv. 2024.","DOI":"10.1101\/2024.01.22.576709"},{"key":"1174_CR3","doi-asserted-by":"crossref","unstructured":"Zeng Y, Lovchykova A, Akiyama T, Liu C, Guo C, Jawahar VM et al. TDP-43 nuclear loss in FTD\/ALS causes widespread alternative polyadenylation changes. bioRxiv. 2024.","DOI":"10.1101\/2024.01.22.575730"},{"key":"1174_CR4","doi-asserted-by":"crossref","unstructured":"Bryce-Smith S, Brown AL, Mehta PR, Mattedi F, Mikheenko A, Barattucci S et al. TDP-43 loss induces extensive cryptic polyadenylation in ALS\/FTD. bioRxiv. 2024.","DOI":"10.1101\/2024.01.22.576625"},{"key":"1174_CR5","doi-asserted-by":"crossref","unstructured":"Alessandrini F, Wright M, Kurosaki T, Maquat LE, Kiskinis E. ALS-Associated TDP-43 Dysfunction Compromises UPF1-Dependent mRNA Metabolism Pathways Including Alternative Polyadenylation and 3`UTR Length. bioRxiv. 2024.","DOI":"10.1101\/2024.01.31.578311"},{"key":"1174_CR6","doi-asserted-by":"crossref","unstructured":"McKeever PM, Sababi AM, Sharma R, Khuu N, Xu Z, Shen SY et al. Single-nucleus multiomic atlas of frontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms. bioRxiv. 2023.","DOI":"10.1101\/2023.12.22.573083"},{"issue":"12","key":"1174_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41580-022-00507-5","volume":"23","author":"S Mitschka","year":"2022","unstructured":"Mitschka S, Mayr C. Context-specific regulation and function of mRNA alternative polyadenylation. Nat Rev Mol Cell Biol. 2022;23(12):779\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"1174_CR8","doi-asserted-by":"publisher","first-page":"111001","DOI":"10.1016\/j.celrep.2022.111001","volume":"39","author":"KL Krus","year":"2022","unstructured":"Krus KL, Strickland A, Yamada Y, Devault L, Schmidt RE, Bloom AJ, et al. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy. Cell Rep. 2022;39(13):111001.","journal-title":"Cell Rep"},{"issue":"6637","key":"1174_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn MW, Melamed Z, L\u00f3pez-Erauskin J, Beccari MS, Ling K, Zuberi A, et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science. 2023;379(6637):1140\u20139.","journal-title":"Science"},{"issue":"5","key":"1174_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","volume":"130","author":"AK Walker","year":"2015","unstructured":"Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, et al. Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130(5):643\u201360.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1174_CR11","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1093\/bioinformatics\/btaa266","volume":"36","author":"R Wang","year":"2020","unstructured":"Wang R, Tian B. APAlyzer: a bioinformatics package for analysis of alternative polyadenylation isoforms. Bioinformatics. 2020;36(12):3907\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"1174_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-023-01592-z","volume":"11","author":"H Riemenschneider","year":"2023","unstructured":"Riemenschneider H, Simonetti F, Sheth U, Katona E, Roth S, Hutten S, et al. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo. Acta Neuropathol Commun. 2023;11(1):112.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1174_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13059-023-02865-5","volume":"24","author":"EL Imada","year":"2023","unstructured":"Imada EL, Wilks C, Langmead B, Marchionni L. REPAC: analysis of alternative polyadenylation from RNA-sequencing data. Genome Biol. 2023;24(1):22.","journal-title":"Genome Biol"},{"issue":"10","key":"1174_CR14","doi-asserted-by":"publisher","first-page":"e0141836","DOI":"10.1371\/journal.pone.0141836","volume":"10","author":"A Amlie-Wolf","year":"2015","unstructured":"Amlie-Wolf A, Ryvkin P, Tong R, Dragomir I, Suh E, Xu Y, et al. Transcriptomic changes due to cytoplasmic TDP-43 expression reveal dysregulation of histone transcripts and nuclear chromatin. PLoS ONE. 2015;10(10):e0141836.","journal-title":"PLoS ONE"},{"issue":"W1","key":"1174_CR15","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1174_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459\u201368.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1174_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-024-00732-w","volume":"19","author":"RP Carmen-Orozco","year":"2024","unstructured":"Carmen-Orozco RP, Tsao W, Ye Y, Sinha IR, Chang K, Trinh VT, et al. Elevated nuclear TDP-43 induces constitutive exon skipping. Mol Neurodegener. 2024;19(1):45.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1174_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40478-021-01239-x","volume":"9","author":"M Hunter","year":"2021","unstructured":"Hunter M, Spiller KJ, Dominique MA, Xu H, Hunter FW, Fang TC, et al. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Acta Neuropathol Commun. 2021;9(1):140.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1174_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41467-024-45646-9","volume":"15","author":"R San Gil","year":"2024","unstructured":"San Gil R, Pascovici D, Venturato J, Brown-Wright H, Mehta P, Madrid San Martin L, et al. A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration. Nat Commun. 2024;15(1):1508.","journal-title":"Nat Commun"},{"issue":"5","key":"1174_CR20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.stemcr.2020.03.023","volume":"14","author":"R Dafinca","year":"2020","unstructured":"Dafinca R, Barbagallo P, Farrimond L, Candalija A, Scaber J, Ababneh NA, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-Derived motor neurons from patients with ALS\/FTD. Stem Cell Rep. 2020;14(5):892\u2013908.","journal-title":"Stem Cell Rep"},{"key":"1174_CR21","doi-asserted-by":"crossref","unstructured":"Imaizumi K, Ideno H, Sato T, Morimoto S, Okano H. Pathogenic mutation of TDP-43 impairs RNA Processing in a cell type-specific manner: implications for the pathogenesis of ALS\/FTLD. eNeuro. 2022;9(3).","DOI":"10.1523\/ENEURO.0061-22.2022"},{"issue":"2","key":"1174_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22(2):167\u201379.","journal-title":"Nat Neurosci"},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.12688\/f1000research.7800.1","volume":"5","author":"D Ortuno","year":"2016","unstructured":"Ortuno D, Carlisle HJ, Miller S. Does inactivation of USP14 enhance degradation of proteasomal substrates that are associated with neurodegenerative diseases? F1000Res. 2016;5:137.","journal-title":"F1000Res"},{"issue":"4","key":"1174_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"11","key":"1174_CR25","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1111\/jcmm.15170","volume":"24","author":"L Montibeller","year":"2020","unstructured":"Montibeller L, Tan LY, Kim JK, Paul P, de Belleroche J. Tissue-selective regulation of protein homeostasis and unfolded protein response signalling in sporadic ALS. J Cell Mol Med. 2020;24(11):6055\u201369.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1174_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12864-023-09676-9","volume":"24","author":"EB Wright","year":"2023","unstructured":"Wright EB, Larsen EG, Coloma-Roessle CM, Hart HR, Bhattacharya MRC. Transmembrane protein 184B (TMEM184B) promotes expression of synaptic gene networks in the mouse hippocampus. BMC Genomics. 2023;24(1):559.","journal-title":"BMC Genomics"},{"issue":"2","key":"1174_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, et al. Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117(2):137\u201349.","journal-title":"Acta Neuropathol"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-025-01174-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:52:37Z","timestamp":1736902357000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-025-01174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1186\/s13041-025-01174-1","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}